help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2006-0251
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, X.
Right arrow Articles by Mitch, W. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, X.
Right arrow Articles by Mitch, W. E.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Endocrinology Vol. 147, No. 9 4160-4168
Copyright © 2006 by The Endocrine Society

Insulin Resistance Accelerates Muscle Protein Degradation: Activation of the Ubiquitin-Proteasome Pathway by Defects in Muscle Cell Signaling

Xiaonan Wang, Zhaoyong Hu, Junping Hu, Jie Du and William E. Mitch

Renal Division (X.W., J.H.), Department of Medicine, Emory University, Atlanta, Georgia 30322; and Nephrology Division (Z.H., J.D., W.E.M.), Baylor College of Medicine, Houston, Texas 77030

Address all correspondence and requests for reprints to: Xiaonan Wang, M.D., Renal Division, WMB 338, Emory University School of Medicine, M/S 1930/001/1AG, 1639 Pierce Drive, Atlanta, Georgia 30322. E-mail: xwang03{at}emory.edu.

Conditions such as acidosis, uremia, and sepsis are characterized by insulin resistance and muscle wasting, but whether the insulin resistance associated with these disorders contributes to muscle atrophy is unclear. We examined this question in db/db mice with increased blood glucose despite high levels of plasma insulin. Compared with control littermate mice, the weights of different muscles in db/db mice and the cross-sectional areas of muscles were smaller. In muscle of db/db mice, protein degradation and activities of the major proteolytic systems, caspase-3 and the proteasome, were increased. We examined signals that could activate muscle proteolysis and found low values of both phosphatidylinositol 3 kinase (PI3K) activity and phosphorylated Akt that were related to phosphorylation of serine 307 of insulin receptor substrate-1. To assess how changes in circulating insulin and glucose affect muscle protein, we treated db/db mice with rosiglitazone. Rosiglitazone improved indices of insulin resistance and abnormalities in PI3K/Akt signaling and decreased activities of caspase-3 and the proteasome in muscle leading to suppression of proteolysis. Underlying mechanisms of proteolysis include increased glucocorticoid production, decreased circulating adiponectin, and phosphorylation of the forkhead transcription factor associated with increased expression of the E3 ubiquitin-conjugating enzymes atrogin-1/MAFbx and MuRF1. These abnormalities were also corrected by rosiglitazone. Thus, insulin resistance causes muscle wasting by mechanisms that involve suppression of PI3K/Akt signaling leading to activation of caspase-3 and the ubiquitin-proteasome proteolytic pathway causing muscle protein degradation.




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
S. M. Phillips, E. I. Glover, and M. J. Rennie
Alterations of protein turnover underlying disuse atrophy in human skeletal muscle
J Appl Physiol, September 1, 2009; 107(3): 645 - 654.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
P. J. Plant, J. R. Bain, J. E. Correa, M. Woo, and J. Batt
Absence of caspase-3 protects against denervation-induced skeletal muscle atrophy
J Appl Physiol, July 1, 2009; 107(1): 224 - 234.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
Z. Q. Wang, Z. E. Floyd, J. Qin, X. Liu, Y. Yu, X. H. Zhang, J. D. Wagner, and W. T. Cefalu
Modulation of Skeletal Muscle Insulin Signaling With Chronic Caloric Restriction in Cynomolgus Monkeys
Diabetes, July 1, 2009; 58(7): 1488 - 1498.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
V. Varma, A. Yao-Borengasser, N. Rasouli, G. T. Nolen, B. Phanavanh, T. Starks, C. Gurley, P. Simpson, R. E. McGehee Jr., P. A. Kern, et al.
Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action
Am J Physiol Endocrinol Metab, June 1, 2009; 296(6): E1300 - E1310.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
L. Zhang, J. Du, Z. Hu, G. Han, P. Delafontaine, G. Garcia, and W. E. Mitch
IL-6 and Serum Amyloid A Synergy Mediates Angiotensin II-Induced Muscle Wasting
J. Am. Soc. Nephrol., March 1, 2009; 20(3): 604 - 612.
[Abstract] [Full Text] [PDF]


Home page
pdiHome page
S.-H. Park and B. Lindholm
DEFINITION OF METABOLIC SYNDROME IN PERITONEAL DIALYSIS
Perit. Dial. Int., February 1, 2009; 29(Supplement_2): S137 - S144.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
H. Crossland, D. Constantin-Teodosiu, S. M. Gardiner, D. Constantin, and P. L. Greenhaff
A potential role for Akt/FOXO signalling in both protein loss and the impairment of muscle carbohydrate oxidation during sepsis in rodent skeletal muscle
J. Physiol., November 15, 2008; 586(22): 5589 - 5600.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Hu, J. D. Klein, J. Du, and X. H. Wang
Cardiac Muscle Protein Catabolism in Diabetes Mellitus: Activation of the Ubiquitin-Proteasome System by Insulin Deficiency
Endocrinology, November 1, 2008; 149(11): 5384 - 5390.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. S. Waddell, L. M. Baehr, J. van den Brandt, S. A. Johnsen, H. M. Reichardt, J. D. Furlow, and S. C. Bodine
The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene
Am J Physiol Endocrinol Metab, October 1, 2008; 295(4): E785 - E797.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. M. Pruznak, L. Hong-Brown, R. Lantry, P. She, R. A. Frost, T. C. Vary, and C. H. Lang
Skeletal and cardiac myopathy in HIV-1 transgenic rats
Am J Physiol Endocrinol Metab, October 1, 2008; 295(4): E964 - E973.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
W. G. Bergen
Measuring in vivo intracellular protein degradation rates in animal systems
J Anim Sci, April 1, 2008; 86(14_suppl): E3 - E12.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. D. DeBoer, X. Zhu, P. R. Levasseur, A. Inui, Z. Hu, G. Han, W. E. Mitch, J. E. Taylor, H. A. Halem, J. Z. Dong, et al.
Ghrelin Treatment of Chronic Kidney Disease: Improvements in Lean Body Mass and Cytokine Profile
Endocrinology, February 1, 2008; 149(2): 827 - 835.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Q. Zhou, J. Du, Z. Hu, K. Walsh, and X. H. Wang
Evidence for Adipose-Muscle Cross Talk: Opposing Regulation of Muscle Proteolysis by Adiponectin and Fatty Acids
Endocrinology, December 1, 2007; 148(12): 5696 - 5705.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
Z. Hu, I. H. Lee, X. Wang, H. Sheng, L. Zhang, J. Du, and W. E. Mitch
PTEN Expression Contributes to the Regulation of Muscle Protein Degradation in Diabetes
Diabetes, October 1, 2007; 56(10): 2449 - 2456.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
D. Constantin, D. Constantin-Teodosiu, R. Layfield, K. Tsintzas, A. J. Bennett, and P. L. Greenhaff
PPAR{delta} agonism induces a change in fuel metabolism and activation of an atrophy programme, but does not impair mitochondrial function in rat skeletal muscle
J. Physiol., August 15, 2007; 583(1): 381 - 390.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
N. Turner, C. R. Bruce, S. M. Beale, K. L. Hoehn, T. So, M. S. Rolph, and G. J. Cooney
Excess Lipid Availability Increases Mitochondrial Fatty Acid Oxidative Capacity in Muscle: Evidence Against a Role for Reduced Fatty Acid Oxidation in Lipid-Induced Insulin Resistance in Rodents
Diabetes, August 1, 2007; 56(8): 2085 - 2092.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. Vermaelen, P. Sirvent, F. Raynaud, C. Astier, J. Mercier, A. Lacampagne, and O. Cazorla
Differential localization of autolyzed calpains 1 and 2 in slow and fast skeletal muscles in the early phase of atrophy
Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1723 - C1731.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society